Modern Diagnostic & Research Centre Limited (BOM:544673)
71.90
-1.35 (-1.84%)
At close: Oct 1, 2026
BOM:544673 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 94 | 7.84 | 4.12 | 1.54 | 46.38 |
Cash & Short-Term Investments | 94 | 7.84 | 4.12 | 1.54 | 46.38 |
Cash Growth | 1098.67% | 90.20% | 168.07% | -96.68% | - |
Accounts Receivable | 157.82 | 127.57 | 103.52 | 80.61 | 90.01 |
Other Receivables | 9.76 | - | - | - | - |
Receivables | 167.58 | 127.57 | 103.52 | 80.61 | 90.01 |
Inventory | 70.84 | 49.17 | 29.71 | 19.49 | 15.1 |
Prepaid Expenses | 5.07 | 5.67 | 3.82 | 3.05 | 1.76 |
Other Current Assets | 96.01 | 55.56 | 39.37 | 17.92 | 25.62 |
Total Current Assets | 433.5 | 245.81 | 180.54 | 122.6 | 178.87 |
Property, Plant & Equipment | 567.02 | 387.84 | 298.41 | 236.36 | 247.29 |
Other Intangible Assets | 15.75 | 9.84 | 8.01 | 0.34 | 3.36 |
Other Long-Term Assets | 169.72 | 2.25 | 7.89 | 6.11 | 57.45 |
Total Assets | 1,186 | 645.74 | 494.86 | 365.41 | 486.96 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 116.3 | 82.56 | 85.63 | 82 | 100.49 |
Accrued Expenses | 12.39 | 7.62 | 31.56 | 27.85 | 28.9 |
Short-Term Debt | 168.42 | 93.6 | 74.44 | 69.53 | 50.36 |
Current Portion of Long-Term Debt | 63.86 | 44.34 | 28.77 | 25.47 | 21.21 |
Current Income Taxes Payable | 17.13 | 10.95 | 6.8 | - | 1.68 |
Other Current Liabilities | 56.31 | 79.66 | 13.14 | 6.99 | 2.35 |
Total Current Liabilities | 434.41 | 318.73 | 240.34 | 211.85 | 204.99 |
Long-Term Debt | 138.68 | 83.01 | 101.36 | 58.09 | 132.43 |
Pension & Post-Retirement Benefits | 16.98 | 14.77 | 12.82 | 10.09 | 6.01 |
Long-Term Deferred Tax Liabilities | 2.75 | 14.21 | 14.6 | 16.54 | 18.65 |
Other Long-Term Liabilities | 7.69 | 7.31 | 8.15 | 9.21 | 7.93 |
Total Liabilities | 600.51 | 438.03 | 377.27 | 305.78 | 370.01 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 150.99 | 110 | 10 | 10 | 10 |
Retained Earnings | 434.48 | 97.71 | 107.58 | 49.63 | 106.95 |
Shareholders' Equity | 585.47 | 207.71 | 117.58 | 59.63 | 116.95 |
Total Liabilities & Equity | 1,186 | 645.74 | 494.86 | 365.41 | 486.96 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 370.97 | 220.95 | 204.58 | 153.1 | 204.01 |
Net Cash (Debt) | -276.97 | -213.11 | -200.45 | -151.56 | -157.63 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -18.34 | -19.37 | -18.22 | -13.78 | -14.33 |
Filing Date Shares Outstanding | 15.1 | 11 | 11 | 11 | 11 |
Total Common Shares Outstanding | 15.1 | 11 | 11 | 11 | 11 |
Working Capital | -0.91 | -72.92 | -59.8 | -89.24 | -26.12 |
Book Value Per Share | 38.77 | 18.88 | 10.69 | 5.42 | 10.63 |
Tangible Book Value | 569.73 | 197.87 | 109.57 | 59.3 | 113.6 |
Tangible Book Value Per Share | 37.73 | 17.99 | 9.96 | 5.39 | 10.33 |
Land | - | - | - | 20.05 | 1.14 |
Machinery | 819.74 | 627.81 | 560.88 | 502.05 | 498.06 |
Construction In Progress | 101.82 | 91.14 | 36 | - | 4.57 |
Leasehold Improvements | 50.83 | 25.21 | 18.32 | - | - |